This week, NMotion, a member of Bio Nebraska, awarded six startups $100,000 each that includes a 12-week program at its new Omaha-based location at Millwork Commons. Bio Nebraska member, Invest Nebraska, is included among the startup’s investors. Read more
Bristol Myers Squibb, a member of Bio Nebraska, announced a collaboration with Disability Solutions to launch the Disability Diversity in Clinical Trials initiative, to make recommendations on how to effectively improve access, engagement, speed of enrollment, and participation of people with disabilities in clinical trials. Read more
An op-ed by Amanda McGill Johnson, Executive Director of Nebraska Cures, and Sasha Forsen, Assistant Director of Bio Nebraska, was published in the Omaha World-Herald on July 17, 2022. Read more
For our July Member Spotlight we talked to Bluestem Biosciences, a Nebraska-based startup company working to enable existing infrastructure in the Midwest for industrialized synthetic biology. Read more
Streck, a member of Bio Nebraska, announced the commercialization of the Streck® Viral Extraction Kit with partner Ceres Nanosciences. Read more
Bio Nebraska and Nebraska Cures released a study, conducted by the Center for Public Affairs Research at the University of Nebraska at Omaha, about the experiences of women in STEM occupations in Nebraska. Read more
DNA Genetics, a member of Bio Nebraska, launched a new website this week that remains focused on the company’s swine genetic advancement program while improving user experience. Read more
The University of Nebraska Medical Center, a member of Bio Nebraska, is part of a four-year grant from the National Institutes of Health to better understand post-COVID symptoms with the goal of improving treatment and health outcomes. Read more
UNL Industry Relations and NU Connections are hosting an hour-long programs overview and update of the Nebraska Business Innovation Act (BIA) for FY 2023. Read more
Bio Nebraska, as well as other biotech-related organizations, joined BIO in signing a letter to congressional leadership urging them to repeal the harmful R&D amortization provision that went into effect earlier this year. Read more